EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy

Zhihui Li, Yuan Yuan, Minglu Liu, Tingting Bo, Xiaolu Ma, Hanqi Wang, Chen Chen, Xiaohui Shi, Hao Wang, Chenguang Bai, Xiang Ni, Chengwei Shao und 3 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Zhihui Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Magnetic Resonance Imaging, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science International Cooperation Project, Science and Technology Commission of Shanghai Municipality, Foundation of Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine the imaging details and diagnostic information of the treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal adenocarcinoma at 9.4T magnetic resonance imaging (MRI) by ex vivo.

Methods

Fifteen cases with locally advanced rectal cancer (LARC) followed by radical surgery after nCRT between September 2022 and February 2023 were recruited. Resected specimens were fixed in a perfluoropolyether‐filled test tube and scanned with a 3.0T and 9.4T MRI system ex vivo. The residual tumor depth and MRI‐based tumor regression grade (TRG) were subjectively assessed and then compared with the pathological findings.

Results

The ex vivo 9.4T T2WI without fat suppression clearly differentiated tumor tissue, fibrosis and normal rectal wall, which clearly corresponded to the pathologic tissues of the rectal specimens. The TRG could be accurately assessed on ex vivo 9.4T images in 13/15 specimens (86.7%), while in 11/15 specimens (73.3%) on ex vivo 3.0T images.

Conclusion

Ex vivo 9.4T MR imaging clearly displayed the components of rectal wall and proved excellent diagnostic performance for evaluating the treatment response to nCRT, which allow radiologists to understand and then assess more accurately the TRG of LARC after nCRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyMagnetic Resonance ImagingAdenocarcinomaHumansMaleFemaleMiddle AgedAgedAdultTreatment OutcomeRectumChemoradiotherapy

Stichwörter der Autor:innen

ex vivomagnetic resonance imagingpathological tumor regressionrectal cancer

Autor:innen und Institutionen

  • Department of Radiology, Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Radiology, Changhai Hospital, The Navy Medical University, Shanghai, China.
  • Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Clinical Neuroscience Center, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • United Imaging Healthcare, Shanghai, China.

ORCID-Profile: Jianping Lu, Fu Shen

Förderung

  • Shanghai Science International Cooperation Project
  • Science and Technology Commission of Shanghai Municipality
  • Foundation of Shanghai Municipal Health Commission
  • National Natural Science Foundation of China
  • Changhai Hospital of Shanghai
  • young medical talents funding project of Shanghai

Zitieren

APA

Li, Z., Yuan, Y., Liu, M., Bo, T., Ma, X., Wang, H., Chen, C., Shi, X., Wang, H., Bai, C., Ni, X., Shao, C., Lu, Y., Lu, J., & Shen, F. (2024). Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy. Cancer Medicine. https://doi.org/10.1002/cam4.70075

Vancouver

Li Z, Yuan Y, Liu M, Bo T, Ma X, Wang H, et al. Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy. Cancer Medicine. 2024. doi:10.1002/cam4.70075

BibTeX
@article{Li2024,
  author = {Li, Zhihui and Yuan, Yuan and Liu, Minglu and Bo, Tingting and Ma, Xiaolu and Wang, Hanqi and Chen, Chen and Shi, Xiaohui and Wang, Hao and Bai, Chenguang and Ni, Xiang and Shao, Chengwei and Lu, Yong and Lu, Jianping and Shen, Fu},
  title = {Rectal adenocarcinoma: Ex vivo 9. 4T MRI —correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70075}
}
Kostenlos starten →